Sign in
4

Changes in Ownership

Acurx Pharmaceuticals, Inc. Filed Acc 0001104659-24-001373

President and CEO acquired 19,737 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
LUCI DAVID P President and CEO 2024-01-03 Option exercise +19,737 $3.55 $70,066 1,048,197 D
Derivatives
LUCI DAVID P President and CEO 2024-01-03 Option exercise · Warrants for Common Stock −19,737 0 D
Loading xslF345X05/tm242052-1_4seq1.xml…